HIGHLIGHTS
- who: JingWei Li from the The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia have published the article: Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes, in the Journal: (JOURNAL) of 23/01/2020
- what: The exception to this approach was for the evaluation of ketonuria in CANVAS, which was assessed using a logistic regression model because urinary ketones were recorded as a categoric variable.
SUMMARY
Even when these criteria are met, the change in the biomarker does not . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.